Erectile Dysfunction and Treatment: An Analysis of Associated Chronic Health Conditions.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
11 2021
Historique:
received: 03 05 2021
revised: 17 07 2021
accepted: 09 08 2021
pubmed: 25 8 2021
medline: 8 2 2022
entrez: 24 8 2021
Statut: ppublish

Résumé

To estimate the association between an erectile dysfunction (ED) diagnosis and other chronic health conditions, as well as, the association between receiving ED treatment and these conditions. Data was reviewed from the IBM MarketScan Claims and Encounters database between 2008-2017 for men ≥18 years. Of this cohort, common chronic health conditions were identified and the associations of receiving ED treatment and having a chronic health condition was then analyzed. We identified 954 512 (38.3%) of the 2 489 069 men ≥18 years with at least one recorded diagnosis of ED, who also had at least one chronic health condition. Eighteen conditions were observed to be positively associated with ED, while eleven conditions were negatively associated. Depression (OR 2.875: 95% CI 2.866, 2.884; P<.001) had the strongest association, while ischemic heart disease (IHD) had the weakest (OR 0.76: 95% CI 0.755, 0.773; P<.001). Our study found that a diagnosis of ED was strongly associated with concomitant diagnoses of depression, hypertension, diabetes and several autoimmune diseases. Receiving treatment for ED varied between chronic health conditions.

Identifiants

pubmed: 34428539
pii: S0090-4295(21)00782-2
doi: 10.1016/j.urology.2021.08.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-154

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Lindsey N Wright (LN)

Univeristy of Utah School of Medicine, Salt Lake City, UT.

Odinachi I Moghalu (OI)

Department of Surgery, Division of Urology, University of Utah Health Science Center, Salt Lake City, UT; Department of Surgery, Division of Urology, Baylor Scott & White Medical Center, Temple, TX.

Rupam Das (R)

Department of Surgery, Surgical Population Analysis Research Core, University of Utah Health Science Center, Salt Lake City, UT.

Joshua Horns (J)

Department of Surgery, Surgical Population Analysis Research Core, University of Utah Health Science Center, Salt Lake City, UT.

Alexander Campbell (A)

Department of Surgery, Surgical Population Analysis Research Core, University of Utah Health Science Center, Salt Lake City, UT.

James Hotaling (J)

Department of Surgery, Division of Urology, University of Utah Health Science Center, Salt Lake City, UT; Department of Surgery, Surgical Population Analysis Research Core, University of Utah Health Science Center, Salt Lake City, UT. Electronic address: jim.hotaling@hsc.utah.edu.

Alexander W Pastuszak (AW)

Department of Surgery, Division of Urology, University of Utah Health Science Center, Salt Lake City, UT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH